Abiraterone CAS: 154229-19-3

Abiraterone ikoreshwa cyane cyane muri kanseri ya prostate irwanya kanseri ya prostate (mCRPC). Nk'umuti ukomeye wo gukumira androgen biosynthesis, yibasira enzyme CYP17A1, ifite akamaro kanini mu gukora testosterone n'izindi androgens. Mu guhagarika iyi enzyme, abiraterone igabanya ikorwa rya androgen haba mu mabya no mu kibyimba ubwacyo, bityo ikagabanya urugero rwa androgens zitera kanseri ya prostate gukura. Mu buvuzi, abiraterone itangwa mu kanwa hamwe na prednisone cyangwa prednisolone kugira ngo igabanye ingaruka mbi zishobora kubaho. Ubu buryo bwo kuvura bwagaragaje akamaro gakomeye mu kunoza umubare w'abazima muri rusange no gutinza iterambere ry'indwara ku barwayi ba kanseri ya prostate babanje guhabwa androgen deprivation therapy (ADT). Byongeye kandi, ingaruka za abiraterone ku kuvura ntizirenze mCRPC. Ubushakashatsi burimo busuzuma ubushobozi bwayo mu byiciro bya mbere bya kanseri ya prostate ndetse no mu bundi buryo bwo kuvura nka chemotherapy n'ubundi buryo bushya bwo kuvura. Uburyo ikora n'inyungu zayo mu buvuzi bikomeje gukorwaho ubushakashatsi mu magerageza atandukanye yo kuvura kugira ngo kunoze umusaruro w'ubuvuzi n'ubuvuzi bw'abarwayi. Muri make, abiraterone ni intambwe ikomeye mu kuvura kanseri, cyane cyane mu kuvura kanseri ya prostate. Ubushobozi bwayo bwo kubangamira ikorwa rya androgen butanga uburyo bwihariye bwo kuvura ibibyimba by’imisemburo, buha abarwayi ubuzima burambye kandi bukongera ubuzima bwiza. Iterambere rikomeje n’inyigo z’ubuvuzi bigaragaza uruhare rwayo rukomeye mu iterambere ry’ingamba zo kuvura kanseri, bitanga icyizere cy’uburyo bushya bwo kwita ku ndwara ya kanseri ku giti cyabo.